A detailed history of Gts Securities LLC transactions in Dexcom Inc stock. As of the latest transaction made, Gts Securities LLC holds 195,800 shares of DXCM stock, worth $15.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
195,800
Previous 58,300 235.85%
Holding current value
$15.2 Million
Previous $6.61 Million 98.52%
% of portfolio
0.03%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$64.0 - $116.06 $1.78 Million - $3.23 Million
27,824 Added 245.53%
39,156 $2.62 Million
Q2 2024

Aug 14, 2024

BUY
$110.31 - $140.45 $1.25 Million - $1.59 Million
11,332 New
11,332 $1.28 Million
Q4 2023

Feb 14, 2024

SELL
$75.49 - $124.16 $678,126 - $1.12 Million
-8,983 Reduced 71.81%
3,527 $437,000
Q3 2023

Nov 15, 2023

BUY
$86.06 - $137.93 $507,840 - $813,924
5,901 Added 89.29%
12,510 $1.17 Million
Q2 2023

Aug 15, 2023

BUY
$112.47 - $130.98 $743,314 - $865,646
6,609 New
6,609 $849 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.